Pharmacokinetic and Safety Study of Cenicriviroc and Acid Reducing Agents When Dosed Alone or in Combination
PHASE1CompletedINTERVENTIONAL
Enrollment
48
Participants
Timeline
Start Date
January 31, 2016
Primary Completion Date
April 11, 2016
Study Completion Date
April 11, 2016
Conditions
Healthy
Interventions
DRUG
Cenicriviroc
DRUG
Omeprazole
DRUG
Famotidine
Trial Locations (1)
33126
SeaView Research, Inc., Miami
All Listed Sponsors
lead
Tobira Therapeutics, Inc.
INDUSTRY
NCT02684799 - Pharmacokinetic and Safety Study of Cenicriviroc and Acid Reducing Agents When Dosed Alone or in Combination | Biotech Hunter | Biotech Hunter